The Supreme Chamber of Physicians is relentless in its efforts to automate the reimbursement process in Poland, which will free doctors from the obligation to determine the degree of drug reimbursement. This administrative obligation not only takes away time that a doctor could spend with a patient, but also exposes doctors to making mistakes unrelated to the profession, but constantly changing reimbursement regulations. What does drug policy look like in Israel, Switzerland and Malta? What solutions should we follow?
Professor Leonid Eidelman of the Israel Medical Association, former president of the World Medical Association WMA and member of the EFMA Liaison Committee; Dr. Jacques de Haller, former president of the Standing Committee of European Doctors CPME and member of the EFMA Liaison Committee; and Dr. Martin Balzan, vice president of the Standing Committee of European Doctors talk about drug policy in Israel, Switzerland and Malta.
IMPORTANT: In none of the countries mentioned is the doctor involved in determining the degree of d... To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].Content locked
If you already have an account, please log in
